GT Biopharma (GTBP) Short term Debt (2010 - 2021)
GT Biopharma (GTBP) posted quarterly Short term Debt of $31000.0 for Q4 2021, down 99.88% year-over-year from $26.3 million in Q4 2020, and down 99.88% quarter-over-quarter from $26.3 million in Q4 2020.
GT Biopharma (GTBP) Short term Debt (2010 - 2021) Analysis & Trends
GT Biopharma (GTBP) has reported Short term Debt for 12 consecutive years, with $31000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Short term Debt fell 99.88% year-over-year to $31000.0; the TTM figure through Dec 2021 stood at $31000.0 (down 99.88% YoY), while the FY2021 annual figure was $31000.0, down 99.88% from the prior year.
- Short term Debt fell to $31000.0 in Q4 2021 per GTBP's latest filing, from $26.3 million in the prior quarter.
- Across five years, Short term Debt topped out at $26.3 million in Q4 2020 and bottomed at $31000.0 in Q4 2021.
- Historically, Short term Debt has averaged $11.1 million across 5 years, with a median of $11.3 million in 2019.
- Annual changes were most pronounced in 2018 — Short term Debt surged 712.32% — and 2021, when it sank 99.88%.
- GT Biopharma's Short term Debt stood at $844000.0 in 2017, then soared by 1164.57% to $10.7 million in 2018, then increased by 23.74% to $13.2 million in 2019, then jumped by 99.16% to $26.3 million in 2020, then tumbled by 99.88% to $31000.0 in 2021.
- Business Quant data shows GTBP's Short term Debt at $31000.0 in Q4 2021, $26.3 million in Q4 2020, and $23.0 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 31,000.00 |
| Dec 31, 2020 | 26.30 Mn |
| Sep 30, 2020 | 23.00 Mn |
| Jun 30, 2020 | 21.84 Mn |
| Mar 31, 2020 | 13.26 Mn |
| Dec 31, 2019 | 13.21 Mn |
| Sep 30, 2019 | 13.14 Mn |
| Jun 30, 2019 | 12.17 Mn |
| Mar 31, 2019 | 11.30 Mn |
| Dec 31, 2018 | 10.67 Mn |
| Sep 30, 2018 | 10.60 Mn |
| Jun 30, 2018 | 6.86 Mn |
| Mar 31, 2018 | 2.93 Mn |
| Jun 30, 2017 | 844,000.00 |
| Mar 31, 2017 | 844,000.00 |
| Dec 31, 2016 | 889,000.00 |
| Sep 30, 2016 | 1.04 Mn |
| Jun 30, 2016 | 1.04 Mn |
| Mar 31, 2016 | 1.04 Mn |
| Dec 31, 2015 | 1.04 Mn |